ResMed (RMD) Revenue — Quarter Ended Dec 31, 2023
Revenue increased in the current quarter. The growth rate slowed compared to the prior quarter and the same quarter last year.
Key takeaway
Quarter ended Dec 31, 2023 · FY2024 Q2
Revenue increased in the current quarter. The growth rate slowed compared to the prior quarter and the same quarter last year.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.2B
Revenue reported for this quarter.
Quarter-over-quarter
+5.5%
Change from the immediately preceding quarter.
Year-over-year
+12.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2023 | $1.1B | +29.2% |
| Jun 30, 2023 | $1.1B | +22.7% |
| Sep 30, 2023 | $1.1B | +16.0% |
| Dec 31, 2023 | $1.2B | +12.5% |
Revenue performance
The reported revenue rose from the immediately preceding quarter. The year-over-year comparison also showed an increase, though the pace of growth moderated.
Quarterly comparison
Compared with the prior quarter, revenue was higher. Versus the same quarter one year earlier, revenue also increased, but the rate of expansion was lower than in the prior quarter.
What to watch
The sequential growth rate decelerated from the prior quarter, which may warrant attention in future periods.